Notably, circulating IL-37 is significantly higher in gastric cancer patients, compared to sex and age matched healthy controls (38), suggesting a possible pro-tumor effect of IL-37, since elevated IL-37 promotes an anti-inflammatory response via suppressing both innate (13) and adaptive immunity (14), resulting in compromised host immune surveillance against malignancy (39). The gene discussed is IL37; the disease is gastric cancer.